News | January 24, 2024
Aster DM Healthcare gets shareholders nod to separate the GCC business
The company also plans to boost its India presence by adding 1,500 beds in the next 2-3 years
The company also plans to boost its India presence by adding 1,500 beds in the next 2-3 years
This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
The company received gross proceeds of approximately US$1.7 million and net proceeds,
BioVaxys has been granted exclusivity while the parties work in good faith on the drafting of a definitive agreement
Funding round led by Sarissa Capital, includes Sun Pharma, Polaris Partners
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
Express Scripts to add Zepbound to National Preferred Formulary
Both the India and GCC entities will be operated by separate dedicated management teams
Acquisition underscores Merck’s ongoing commitment to developing treatments for neurodegenerative diseases
EBITDA for Q2 FY24 at Rs. 71.2 crore as compared to Rs. 79.9 crore QoQ
Subscribe To Our Newsletter & Stay Updated
